These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 36750945

  • 1. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
    Gao Y, Yang LL, Dai YL, Shen Z, Zhou Q, Zou CC.
    Orphanet J Rare Dis; 2023 Feb 07; 18(1):25. PubMed ID: 36750945
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.
    Zhou Q, Chao YQ, Dai YL, Gao Y, Shen Z, Dong GP, Zou CC.
    BMC Pediatr; 2024 Oct 01; 24(1):627. PubMed ID: 39354420
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.
    Guo H, Fu J, Zhou Y, Luo F, Cheng R.
    BMC Pediatr; 2024 Jan 10; 24(1):32. PubMed ID: 38200464
    [Abstract] [Full Text] [Related]

  • 5. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E, Harris M, Hughes I, Crock PA, Ambler G, Verge CF, Bergman P, Werther G, Craig ME, Choong CS, Davies PSW, PWS and OZGROW collaboration.
    Growth Horm IGF Res; 2017 Jun 10; 34():1-7. PubMed ID: 28427039
    [Abstract] [Full Text] [Related]

  • 6. Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome.
    Cheng RQ, Ying YQ, Qiu ZQ, Fu JF, Gong CX, Yang YL, Shi W, Li H, Ma MS, Wang CY, Liu M, Chen JJ, Su C, Luo XP, Luo FH, Lu W.
    World J Pediatr; 2023 May 10; 19(5):438-449. PubMed ID: 36564648
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of growth hormone on sleep-disordered breathing in Malaysian children with Prader-Willi syndrome: a retrospective study.
    Tan YT, Azanan MS, Hng SY, Eg KP, Jalaludin MY, Thong MK, Tae SK, Samingan N, Anuar A, Nathan AM.
    J Clin Sleep Med; 2024 Aug 01; 20(8):1291-1299. PubMed ID: 38557309
    [Abstract] [Full Text] [Related]

  • 8. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE, Lindberg A, Heissler J, Wollmann HA, Camacho-Hübner C, Hokken-Koelega AC, KIGS Steering Committee.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1702-1711. PubMed ID: 28323917
    [Abstract] [Full Text] [Related]

  • 9. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY, Myers S, Carrel A, Allen D.
    Pediatrics; 2002 Feb 01; 109(2):E35. PubMed ID: 11826245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
    Lämmer C, Weimann E.
    Wien Med Wochenschr; 2007 Feb 01; 157(3-4):82-8. PubMed ID: 17340066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.
    Koizumi M, Konishi A, Etani Y, Ida S, Kawai M.
    Clin Endocrinol (Oxf); 2022 Mar 01; 96(3):346-352. PubMed ID: 34750859
    [Abstract] [Full Text] [Related]

  • 15. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
    Stipančić G, Požgaj Šepec M, La Grasta Sabolić L.
    Acta Clin Croat; 2018 Dec 01; 57(4):744-755. PubMed ID: 31168212
    [Abstract] [Full Text] [Related]

  • 16. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
    Lundberg E, Kriström B, Zouater H, Deleskog A, Höybye C.
    BMC Endocr Disord; 2020 Apr 29; 20(1):55. PubMed ID: 32349731
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C.
    Endocrine; 2012 Apr 29; 41(2):191-9. PubMed ID: 22081257
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M.
    J Pediatr Endocrinol Metab; 1996 Apr 29; 9(3):393-400. PubMed ID: 8887149
    [Abstract] [Full Text] [Related]

  • 19. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct 29; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 20. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep 29; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.